The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells
- PMID: 16769892
- PMCID: PMC1480458
- DOI: 10.1073/pnas.0600225103
The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells
Abstract
Regulatory T cells that express the Foxp3 transcription factor play important roles in preventing autoimmune diseases. Although several studies have demonstrated that the lack of the forkhead DNA-binding domain of Foxp3 caused severe autoimmune disease in scurfy mutant mice, the other functional domains of Foxp3 are less well characterized. Here, we show that the deletion of glutamic acid (DeltaE250) in the leucine-zipper domain of Foxp3 causes a loss of hyporesponsiveness when compared with wild-type Foxp3 upon antigenic stimulation. CD4 T cells that ectopically express the glutamic acid mutant show significant losses of suppressor activity both in vitro and in vivo. We also demonstrate that regulation of both Th1- and Th2-type cytokine secretion in CD4 T cells that express wild-type Foxp3 is significantly altered by the deletion of glutamic acid. Defects are also observed in the expression of adhesion molecules, such as l-selectin (CD62L) and CD103, suggesting an important role of glutamic acid in the migratory behavior of regulatory T cells. Finally, this mutation reduces transcriptional repressor activity and impairs the homodimerization of Foxp3. Taken together, our results provide insight into the mechanism that controls autoimmune diseases via the deletion of this single glutamic acid residue in the leucine-zipper domain of Foxp3.
Conflict of interest statement
Conflict of interest statement: No conflicts declared.
Figures






Similar articles
-
Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor.J Immunol. 2006 Sep 1;177(5):3133-42. doi: 10.4049/jimmunol.177.5.3133. J Immunol. 2006. PMID: 16920951
-
Absence of leucine zipper in the natural FOXP3Delta2Delta7 isoform does not affect dimerization but abrogates suppressive capacity.PLoS One. 2009 Jul 1;4(7):e6104. doi: 10.1371/journal.pone.0006104. PLoS One. 2009. PMID: 19568423 Free PMC article.
-
FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.Int Immunol. 2007 Jul;19(7):825-35. doi: 10.1093/intimm/dxm043. Epub 2007 Jun 22. Int Immunol. 2007. PMID: 17586580
-
Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells.Curr Opin Immunol. 2011 Oct;23(5):641-7. doi: 10.1016/j.coi.2011.07.012. Epub 2011 Aug 11. Curr Opin Immunol. 2011. PMID: 21840184 Review.
-
From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics.Clin Exp Immunol. 2019 Jul;197(1):14-23. doi: 10.1111/cei.13194. Epub 2018 Sep 17. Clin Exp Immunol. 2019. PMID: 30076771 Free PMC article. Review.
Cited by
-
Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications.Front Immunol. 2021 Apr 12;12:626172. doi: 10.3389/fimmu.2021.626172. eCollection 2021. Front Immunol. 2021. PMID: 33912156 Free PMC article. Review.
-
IPEX Syndrome, FOXP3 and Cancer.J Syndr. 2013 Jun;1(1):7. doi: 10.13188/2380-6036.1000001. J Syndr. 2013. PMID: 25844400 Free PMC article.
-
FOXP3 Isoforms Expression in Cervical Cancer: Evidence about the Cancer-Related Properties of FOXP3Δ2Δ7 in Keratinocytes.Cancers (Basel). 2023 Jan 5;15(2):347. doi: 10.3390/cancers15020347. Cancers (Basel). 2023. PMID: 36672296 Free PMC article.
-
FoxP3 interacts with linker histone H1.5 to modulate gene expression and program Treg cell activity.Genes Immun. 2011 Oct;12(7):559-67. doi: 10.1038/gene.2011.31. Epub 2011 Jun 9. Genes Immun. 2011. PMID: 21654845 Free PMC article.
-
Domain tethering impacts dimerization and DNA-mediated allostery in the human transcription factor FoxP1.J Chem Phys. 2023 May 21;158(19):195101. doi: 10.1063/5.0138782. J Chem Phys. 2023. PMID: 37184020 Free PMC article.
References
-
- Sakaguchi S. Annu. Rev. Immunol. 2004;22:531–562. - PubMed
-
- Gavin M., Rudensky A. Curr. Opin. Immunol. 2003;15:690–696. - PubMed
-
- Baecher-Allan C., Viglietta V., Hafler D. A. Semin. Immunol. 2004;16:89–98. - PubMed
-
- Schubert L. A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S. F. J. Biol. Chem. 2001;276:37672–37679. - PubMed
-
- Hori S., Nomura T., Sakaguchi S. Science. 2003;299:1057–1061. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials